<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03127943</url>
  </required_header>
  <id_info>
    <org_study_id>16-0068</org_study_id>
    <nct_id>NCT03127943</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine</brief_title>
  <official_title>Pilot Study: Comparison of Buffered 1% vs. Non-Buffered 1% Lidocaine Used in Dental and Oral Surgical Procedures: Clinical Outcomes Mandible</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the clinical impact of Buffered 1% lidocaine with epinephrine as compared to the
      Non-buffered 1% lidocaine with epinephrine in dental and oral surgical procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      Based on the discovery of its topical and locally injected anesthetic effects at the end of
      the 19th century, cocaine was rapidly adopted as a means of blocking painful sensory impulses
      from the periphery during surgical procedures.(1) In the last decade local anesthetics have
      been administered more often, alone or in combination with IV or inhalation anesthetics for
      most surgical procedures. For clinical procedures in the head and neck the local anesthetic
      drugs have been combined with a vasoconstrictor, usually epinephrine, to prolong the
      anesthetic effect at the locally injected anatomic site. To achieve pulpal and periosteal
      anesthesia by nerve or field block for procedures in dentistry, lidocaine at a 2%
      concentration has been preferred by clinicians for its reliable outcomes. To prolong the
      shelf life of the vasopressor, the drug combination must be formulated with a low pH,
      approximately pH 3.5 for lidocaine with 1/100k epinephrine (Epi).

      With a better understanding of the pharmacology, new options for improving local anesthetic
      effectiveness including buffering the commercially supplied drugs to a neutral pH just prior
      to injection, continue to emerge.(2) When injected, the low pH causes the &quot;sting&quot; felt by
      patients on injection. Buffering to a neutral pH eliminates this discomfort and makes the
      maximum concentration of the non-ionized form of the anesthetic drug immediately available to
      the targeted nerve membrane.(3-7) Until recently, buffering local anesthetics containing Epi
      followed with bicarbonate just prior to injection was impractical for the quantities used in
      intraoral procedures. However, today we do have options to efficiently accomplish this
      buffering technique.(Anutra Medical, Research TrianglePark, NC).

      Buffering local anesthetics just prior to use produces positive outcomes including less
      &quot;sting&quot; on injection, faster onset of the drug, and possibly added drug potency, ie the same
      positive clinical effect at lower dosage. In pilot studies with healthy adults as their own
      controls investigators have shown that Buffered 1% lidocaine with 1/100k Epi was as effective
      as Non-buffered 2% lidocaine with 1/100k Epi for pulpal anesthesia on a 1st molar or canine
      after nerve block in the mandible or field block in the maxilla-Phase one of this study.(8,9)
      These outcomes could be beneficial for performing multiple procedures in children whose
      lidocaine dosage is limited by body weight or others with chronic liver disease.

      Rationale:

      The recently reported results from the two clinical studies involving buffered lidocaine with
      Epi have led to clinicians questioning whether the Buffered 1% lidocaine with Epi might be as
      effective for achieving pulpal and periosteal anesthesia for dental procedures as
      Non-Buffered 1% lidocaine with Epi-Phase two of this study, outcomes not usually considered
      by most clinicians. This protocol addresses that question.

      Specific Aims:

      Compare clinical depths of pulpal anesthesia for maxillary(Phase one) and mandibular(Phase
      two) molar and canine teeth at 30min intervals Post-injection of lidocaine Assess pain levels
      during injection Assess time after injection to lower lip numb

      Hypotheses:

      No differences exist in anesthetic depth for pulpal anesthesia after intraoral injection
      mandibular nerve block between Buffered 1% lidocaine with 1/100k epinephrine as compared to
      Non-buffered 1% lidocaine with 1/100k epinephrine.

      Subjects will serve as their own controls in a cross-over AB/BA study design which is uniform
      within sequences, uniform within periods, and balanced
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">April 1, 2018</completion_date>
  <primary_completion_date type="Actual">April 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Time to Pulpal Response After Mandibular Molar Anesthesia</measure>
    <time_frame>Every 30 minutes up to 120 minutes Total</time_frame>
    <description>Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Time to Pulpal Response After Mandibular Canine Anesthesia</measure>
    <time_frame>30 minute intervals up to 120 minutes</time_frame>
    <description>Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Buffered 1% lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In week One, Each subject would be injected intraorally with either anesthetic (Buffered 1% lidocaine with 1/100,00 epinephrine) or (Non-buffered 1% lidocaine with 1/100,00 epinephrine to block the Inferior alveolar, Lingual and Buccal nerves.
At least a week later injections for the same nerves would involve the alternate anesthetic. Mandibular molar and canine tested for pulpal anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-buffered 1% lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In week Two, Each subject would be injected intraorally with the alternate anesthetic (Buffered 1% lidocaine with 1/100,00 epinephrine) or (Non-buffered 1% lidocaine with 1/100,00 epinephrine to block the Inferior alveolar, Lingual and Buccal nerves.
At least a week later injections for the same nerves would involve the alternate anesthetic. Mandibular molar and canine tested for pulpal anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Efficacy for mandibular molar and canine anesthesia</description>
    <arm_group_label>Buffered 1% lidocaine</arm_group_label>
    <arm_group_label>Non-buffered 1% lidocaine</arm_group_label>
    <other_name>xylocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age 18-30 years American Society Anesthesiologists I,II

        Exclusion Criteria:

        Allergy to lidocaine class of anesthetic drugs Local anesthetic drug use in past week
        Current symptoms in teeth or oral mucosa
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Turvey, DDS</last_name>
    <role>Study Chair</role>
    <affiliation>UNC Oral and Maxillofacial Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raymond P White Jr, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UNC School of Dentistry</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>April 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <results_first_submitted>January 14, 2019</results_first_submitted>
  <results_first_submitted_qc>January 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">February 6, 2019</results_first_posted>
  <last_update_submitted>January 14, 2019</last_update_submitted>
  <last_update_submitted_qc>January 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lidocaine, mandible</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT03127943/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine</title>
          <description>At each treatment visit participants were injected to block the Inferior alveolar, Lingual and Buccal nerves.</description>
        </group>
        <group group_id="P2">
          <title>Non-Buffered 1% Lidocaine, Then Buffered 1% Lidocaine</title>
          <description>At each treatment visit participants were injected to block the Inferior alveolar, Lingual and Buccal nerves.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (1 Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Participants who were to receive either Buffered 1% lidocaine or Non-Buffered 2% Lidocaine</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" lower_limit="22.5" upper_limit="25.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Time to Pulpal Response After Mandibular Molar Anesthesia</title>
        <description>Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no</description>
        <time_frame>Every 30 minutes up to 120 minutes Total</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine</title>
            <description>All subjects who received Buffered 1% Lidocaine</description>
          </group>
          <group group_id="O2">
            <title>Non-buffered 1% Lididocaine, the Buffered 1% Lidocaine</title>
            <description>All subjects who received Non_buffered Lidocaine</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time to Pulpal Response After Mandibular Molar Anesthesia</title>
          <description>Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" spread="37.2"/>
                    <measurement group_id="O2" value="106" spread="41.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Time to Pulpal Response After Mandibular Canine Anesthesia</title>
        <description>Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no</description>
        <time_frame>30 minute intervals up to 120 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine</title>
            <description>All subjects who received Buffered 1% Lidocaine</description>
          </group>
          <group group_id="O2">
            <title>Non-buffered 1% Lididocaine, the Buffered 1% Lidocaine</title>
            <description>All subjects who received Non_buffered Lidocaine</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time to Pulpal Response After Mandibular Canine Anesthesia</title>
          <description>Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.3" spread="44.7"/>
                    <measurement group_id="O2" value="97.5" spread="43.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Every 30 minutes up to 120 minutes total</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Buffered 1% Lidocaine</title>
          <description>Each subject was injected intraorally with Buffered 1% Lidocaine (with 1/100,00 epinephrine) to block the Inferior alveolar, Lingual, and Buccal nerves. Mandibular molar and canine tested for pulpal anesthesia.</description>
        </group>
        <group group_id="E2">
          <title>Non-Buffered 1% Lidocaine</title>
          <description>Each subject was injected intraorally with Non-buffered 1% Lidocaine (with 1/100,00 epinephrine) to block the Inferior alveolar, Lingual and Buccal nerves. Mandibular molar and canine tested for pulpal anesthesia.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Raymond P. White Jr DDS, PhD</name_or_title>
      <organization>UNC Department of Oral and Maxillofacial Surgery</organization>
      <phone>919-537-3944</phone>
      <email>ray_white@unc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

